Similar articles

• Meeting unmet needs in patients with sepsis: the role of drotrecogin alfa (activated).

  McEvoy M. McEvoy M. Am J Crit Care. 2003 Sep;12(5):398; author reply 398. Am J Crit Care. 2003. PMID: 14503421 No abstract available.
• Meeting unmet needs in patients with sepsis: the role of drotrecogin alfa (activated).

  Morris PE. Morris PE. Am J Crit Care. 2003 Mar;12(2):94-7. Am J Crit Care. 2003. PMID: 12625165 No abstract available.
• Drotrecogin alfa (activated) for severe sepsis.

  [No authors listed] [No authors listed] Drug Ther Bull. 2006 Jan;44(1):5-8. doi: 10.1136/dtb.2006.4415. Drug Ther Bull. 2006. PMID: 16425899 Review.
• Should health care money in South Africa be spent on drotrecogin alfa?

  Taylor B, Burns D, van de Wal BW, MBewu T, Keeton GR. Taylor B, et al. S Afr Med J. 2003 Jul;93(7):500-1. S Afr Med J. 2003. PMID: 12939917 No abstract available.
• Management challenge with drotrecogin alfa (activated).

  Vanscoy GJ. Vanscoy GJ. Am J Health Syst Pharm. 2002 Feb 15;59 Suppl 1:S23-9. doi: 10.1093/ajhp/59.suppl_1.S23. Am J Health Syst Pharm. 2002. PMID: 11885411 Review.